2-oxy-benzoxazinone derivatives for the treatment of obesity
US8877750B2 · kind B2 · utility
0Cited by
7References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 23, 2010 |
| Grant date | Nov 4, 2014 |
| Priority date | — |
| Expiry date | Dec 23, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C271/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of a compound comprising formula (I):or a salt, ester, amide or prodrug thereof in the inhibition of an enzyme whose preferred mode of action is to catalyse the hydrolysis of an ester functionality, e.g. in the control and inhibition of unwanted enzymes in products and processes. The compounds are also useful in medicine e.g. in the treatment of obesity and related conditions. The invention also relates to novel compounds within formula (I), to processes for preparing them and pharmaceutical compositions containing them.In formula (I) A is a 6-membered aromatic or heteroaromatic ring; and
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.